Rossmore Private Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
2,793
-1,079
-28% -$87K 0.02% 289
2026
Q1
$338K Sell
3,872
-84
-2% -$8.05K 0.03% 237
2025
Q4
$383K Hold
3,956
0.03% 224
2025
Q3
$377K Sell
3,956
-55
-1% -$5.06K 0.04% 208
2025
Q2
$350K Sell
4,011
-1,083
-21% -$91.8K 0.04% 209
2025
Q1
$458K Sell
5,094
-3,930
-44% -$352K 0.06% 181
2024
Q4
$721K Sell
9,024
-3,908
-30% -$338K 0.09% 150
2024
Q3
$1.16M Hold
12,932
0.14% 115
2024
Q2
$1.02M Sell
12,932
-699
-5% -$57.3K 0.13% 119
2024
Q1
$1.19M Buy
13,631
+283
+2% +$24.2K 0.16% 109
2023
Q4
$1.1M Sell
13,348
-2
-0% -$152 0.16% 111
2023
Q3
$1.05M Sell
13,350
-6
-0% -$502 0.16% 106
2023
Q2
$1.18M Hold
13,356
0.18% 103
2023
Q1
$1.08M Sell
13,356
-654
-5% -$53.3K 0.17% 106
2022
Q4
$1.05M Sell
14,010
-202
-1% -$16.4K 0.17% 103
2022
Q3
$1.15M Sell
14,212
-382
-3% -$34.3K 0.21% 88
2022
Q2
$1.31M Hold
14,594
0.23% 87
2022
Q1
$1.62M Sell
14,594
-100
-0.7% -$10.6K 0.25% 86
2021
Q4
$1.52M Buy
14,694
+62
+0.4% +$7.18K 0.24% 86
2021
Q3
$1.83M Hold
14,632
0.31% 75
2021
Q2
$1.82M Buy
14,632
+96
+0.7% +$12.1K 0.31% 77
2021
Q1
$1.72M Buy
14,536
+907
+7% +$106K 0.32% 76
2020
Q4
$1.6M Buy
13,629
+2,485
+22% +$274K 0.32% 78
2020
Q3
$1.16M Buy
11,144
+1,662
+18% +$167K 0.27% 88
2020
Q2
$869K Buy
9,482
+1,965
+26% +$188K 0.24% 89
2020
Q1
$678K Buy
7,517
+2,124
+39% +$226K 0.23% 92
2019
Q4
$612K Buy
5,393
+1,402
+35% +$154K 0.19% 80
2019
Q3
$434K Hold
3,991
0.15% 96
2019
Q2
$389K Buy
3,991
+1,452
+57% +$133K 0.14% 93
2019
Q1
$231K Hold
2,539
0.09% 118
2018
Q4
$231K Buy
2,539
+100
+4% +$9.35K 0.1% 115
2018
Q3
$240K Buy
2,439
+50
+2% +$4.62K 0.1% 117
2018
Q2
$205K Sell
2,389
-430
-15% -$35.9K 0.13% 104
2018
Q1
$226K Buy
2,819
+383
+16% +$31.6K 0.23% 87
2017
Q4
$197K Buy
+2,436
New +$195K 0.2% 93

Other funds holding MDT

Rossmore Private Capital's MDT Position: Q2 2026 in Review

Rossmore Private Capital reduced its Medtronic (MDT) stake by 28% in Q2 2026, selling an estimated $87K and leaving 2,793 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #289.

Rossmore Private Capital first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.83M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Rossmore Private Capital held 2,793 shares of Medtronic worth $221K as of Q2 2026.
  • Rossmore Private Capital sold 1,079 Medtronic shares in Q2 2026, an estimated $87K.
  • Medtronic made up 0.02% of Rossmore Private Capital's portfolio in Q2 2026, its #289 holding.
  • Rossmore Private Capital first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
  • Rossmore Private Capital's Medtronic position peaked at $1.83M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.